Thermo Fisher Scientific sells scientific instruments and laboratory equipment, diagnostics consumables, and life science reagents... Show more
Thermo Fisher Scientific maintains a quarterly dividend payment schedule. The most recent quarterly dividend is $0.47 per share, resulting in an annualized rate of $1.88. This produces a trailing yield near 0.36%. The company follows a dividend growth strategy rather than targeting high current yields. Its policy emphasizes sustainable increases supported by robust earnings and cash generation in the life sciences sector. Investors view TMO as a modest-yield dividend growth stock suitable for those prioritizing long-term income expansion over immediate high payouts.
Thermo Fisher Scientific has demonstrated consistent dividend growth. The firm increased its quarterly payout for nine straight years. Recent raises include moving from $0.43 to $0.47 per share in 2026. Historical data shows steady upward adjustments, with annualized growth rates averaging 10% over the past year and higher over longer periods. Payments have remained uninterrupted, reflecting a deliberate strategy of returning capital to shareholders while funding operations and acquisitions. This track record positions TMO as a reliable dividend growth name in its industry.
The dividend appears highly sustainable. The payout ratio of approximately 9-10% shows that only a small portion of earnings is distributed, leaving substantial coverage from both net income and free cash flow. Strong balance sheet metrics, including manageable debt levels, further support ongoing payments. With earnings and cash generation well exceeding dividend obligations, the company maintains significant flexibility for increases or other capital allocation priorities. No signs of strain appear in current financials.
Within the life sciences and analytical instruments sector, Thermo Fisher Scientific’s yield of 0.36% sits below many peers. Comparable companies such as Danaher (DHR) and Agilent Technologies (A) also feature low single-digit yields with similar growth-oriented policies. TMO’s profile aligns with the industry norm of modest yields paired with strong growth potential rather than high-income characteristics seen in utilities or consumer staples.
Tickeron’s AI Screener is an AI-powered stock and ETF discovery tool that helps traders and investors filter the market based on technical patterns, fundamentals, trends, volatility, and AI-driven signals. Users can scan thousands of stocks and ETFs using customizable filters such as industry, market capitalization, technical indicators, price patterns, and performance metrics. The screener helps identify dividend stocks, income-focused investments, trending stocks, breakout candidates, and market opportunities more efficiently than manual screening.
Thermo Fisher Scientific may suit dividend growth investors focused on long-term compounding and capital appreciation. Its low payout ratio and consistent increases provide a foundation for future dividend expansion. Income-oriented investors seeking higher current yields may find the modest return less appealing compared with higher-yielding sectors. Conservative long-term holders could value the company’s financial stability and sector leadership. The stock offers balanced exposure for those prioritizing sustainability and growth over immediate income. All assessments remain analytical and do not constitute investment recommendations.
The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.
Disclaimers and Limitationsa developer of analytical and environment monitoring instruments
Industry MedicalSpecialties